Healthpeak Properties, Inc. PEAK
Institutional shares held
633 Million
786K
calls
103K
puts
Total value of holdings
$12B
$14.9M
calls
$1.96M
puts
Market Cap
$10.2B
539,580,992
Shares Out.
Institutional ownership
117.25%
# of Institutions
817
We take great care to ensure that the data presented and summarized in this overview for HEALTHPEAK PROPERTIES, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding PEAK
View all-
Vanguard Group Inc Valley Forge, PA112MShares$2.12 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY77MShares$1.46 Billion0.03% of portfolio
-
State Street Corp Boston, MA47.4MShares$900 Million0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY19.7MShares$373 Million0.03% of portfolio
-
Invesco Ltd. Atlanta, GA19.1MShares$363 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA18.4MShares$348 Million0.03% of portfolio
-
Principal Financial Group Inc Des Moines, IA18.1MShares$344 Million0.2% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA17.3MShares$328 Million1.27% of portfolio
-
Morgan Stanley New York, NY12.3MShares$234 Million0.02% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA11.2MShares$213 Million2.31% of portfolio
Latest Institutional Activity in PEAK
Top Purchases
Top Sells
About PEAK
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
Insider Transactions at PEAK
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 03
2025
|
John T Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
6,718
-0.82%
|
$134,360
$20.06 P/Share
|
|
Feb 16
2025
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
810
-3.91%
|
$15,390
$19.59 P/Share
|
|
Feb 15
2025
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
500
-2.36%
|
$9,500
$19.59 P/Share
|
|
Feb 10
2025
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-1.85%
|
$7,600
$19.86 P/Share
|
|
Feb 10
2025
|
Scott M Brinker President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,393
-2.75%
|
$102,467
$19.86 P/Share
|
|
Feb 07
2025
|
John T Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,141
+2.41%
|
-
|
|
Jan 31
2025
|
Lisa A Alonso EVP and Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,480
-6.41%
|
$29,600
$20.51 P/Share
|
|
Jan 30
2025
|
Lisa A Alonso EVP and Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,948
+13.78%
|
-
|
|
Dec 11
2024
|
John T Thomas Director |
SELL
Bona fide gift
|
Direct |
48,775
-5.77%
|
-
|
|
Sep 04
2024
|
Thomas Klaritch COO |
SELL
Bona fide gift
|
Direct |
6,488
-1.93%
|
-
|
|
Apr 26
2024
|
Katherine M Sandstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+17.55%
|
-
|
|
Apr 26
2024
|
Tommy G Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+7.27%
|
-
|
|
Apr 26
2024
|
Richard A. Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+13.95%
|
-
|
|
Apr 26
2024
|
R Kent Griffin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+12.06%
|
-
|
|
Apr 26
2024
|
Pamela Shelley Kessler Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+19.45%
|
-
|
|
Apr 26
2024
|
Sara Grootwassink Lewis Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+20.97%
|
-
|
|
Apr 26
2024
|
Ava Lias Booker Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+32.48%
|
-
|
|
Apr 26
2024
|
Brian G. Cartwright Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+13.18%
|
-
|
|
Apr 26
2024
|
James B. Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,575
+35.02%
|
-
|
|
Apr 03
2024
|
John T Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,763
+2.51%
|
-
|
Last 12 Months Summary
Buy / Acquisition
113K
Shares
From
11
Insiders
| Grant, award, or other acquisition | 113K shares |
|---|
Sell / Disposition
70.6K
Shares
From
5
Insiders
| Payment of exercise price or tax liability | 15.3K shares |
|---|---|
| Bona fide gift | 55.3K shares |